Discontinuation report SEBIVO

Last updated on 2019-11-06 History
Report ID 89042
Drug Identification Number 02288389
Brand name SEBIVO
Common or Proper name SEBIVO 600MG 2 X 14
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Active Ingredient(s) TELBIVUDINE
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 2 X 14
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-11-01
Actual discontinuation date 2019-11-01
Remaining supply date 2019-11-01
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply Expiration date of remaining supply: April 30, 2020
Company comments
Health Canada comments
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2019-07-10 English Compare
v2 2019-07-10 French Compare
v3 2019-07-10 English Compare
v4 2019-07-10 French Compare
v5 2019-09-05 English Compare
v6 2019-11-06 English Compare
v7 2019-11-06 French Compare